Pacific Biosciences of California Inc (NAS:PACB)
$ 1.645 -0.025 (-1.5%) Market Cap: 448.02 Mil Enterprise Value: 817.48 Mil PE Ratio: 0 PB Ratio: 0.69 GF Score: 58/100

Pacific Biosciences of California Inc at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 10, 2021 / 07:25PM GMT
Release Date Price: $32.08 (+2.23%)
Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst

Awesome. I think we're live. Yes, we're live. So thanks again, everybody, for making it. Sorry about being a little late here. There was a technical difficulty on our side. Luke Sergott, I cover life science tools, diagnostics here at Barclays. I have the pleasure of introducing Christian Henry and Susan Kim of PacBio, a newly minted management team.

And I think Christian is going to run through some slides and then we can get into the Q&A.

Christian O. Henry
Pacific Biosciences of California, Inc. - President, CEO & Director

That sounds great. Okay, let's do it. I'll share my screen and we'll get going.

All right. Before we get started, I'd just like to say thank you to Barclays for hosting us today. And we have our obligatory safe harbor statement.

So I've been asked to remind you that my comments today could include forward-looking statements. You should refer to our SEC filings for a discussion of the risks and uncertainties that could cause

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot